We found that GALR1, GALR2 and GALR3 relative immunoreactivity (comparing myenteric plexuses close to CRC cells vs. plexuses distant from cancer invasion) did not correlate with the overall survival of CRC patients (Figure 4A, B, and C, respectively; Table 1). The gene discussed is GALR1; the disease is colorectal carcinoma.